¿Es la digoxina un estrógeno diseñador?

Same author

Multiple endocrine neoplasia type 1: new clinical and basic findings.

Trends in endocrinology and metabolism: TEM·2001

Same author

Osteoporosis and low bone mass in premenopausal and perimenopausal women.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2001

Same author

Left ventricular midwall function improves with antihypertensive therapy and regression of left ventricular hypertrophy in patients with asymptomatic hypertension.

The American journal of cardiology·2001

Same author

Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1.

The Journal of clinical endocrinology and metabolism·2001

Same author

Antibiotics for myocardial infarction? A possible role of infection in atherogenesis and acute coronary syndromes.

Drugs·1999

Same author

Hypocalcemia associated with alendronate.

Annals of internal medicine·1999

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Videos de Experimentos Relacionados

¿Es la digoxina un estrógeno diseñador?

Videos de Conceptos Relacionados

Multiple endocrine neoplasia type 1: new clinical and basic findings.

Osteoporosis and low bone mass in premenopausal and perimenopausal women.

Left ventricular midwall function improves with antihypertensive therapy and regression of left ventricular hypertrophy in patients with asymptomatic hypertension.

Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1.

Antibiotics for myocardial infarction? A possible role of infection in atherogenesis and acute coronary syndromes.

Hypocalcemia associated with alendronate.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Videos de Experimentos Relacionados

¿Es la digoxina un estrógeno diseñador?

Videos de Conceptos Relacionados

Artículos Relacionados

Multiple endocrine neoplasia type 1: new clinical and basic findings.

Osteoporosis and low bone mass in premenopausal and perimenopausal women.

Left ventricular midwall function improves with antihypertensive therapy and regression of left ventricular hypertrophy in patients with asymptomatic hypertension.

Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1.

Antibiotics for myocardial infarction? A possible role of infection in atherogenesis and acute coronary syndromes.

Hypocalcemia associated with alendronate.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.